Mrv1909 04062120242D 19 20 0 0 1 0 999 V2000 -1.7843 1.2411 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.7836 0.4153 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -1.0686 0.0038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3566 0.4153 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.3584 0.0038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0704 0.4153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7854 0.0038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.4942 0.4168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.2090 0.0091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.2125 -0.8191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.9245 -1.2305 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.4979 -1.2334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7837 -0.8221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.4899 0.0038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.2121 0.4126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.9237 0.0009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.9245 -0.8265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.2109 -1.2411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.4931 -0.8262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 1 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 4 5 1 0 0 0 0 5 6 1 0 0 0 0 6 7 1 0 0 0 0 8 7 1 0 0 0 0 9 8 2 0 0 0 0 10 9 1 0 0 0 0 10 11 1 0 0 0 0 12 10 2 0 0 0 0 13 12 1 0 0 0 0 7 13 2 0 0 0 0 14 2 1 0 0 0 0 14 15 2 0 0 0 0 15 16 1 0 0 0 0 16 17 2 0 0 0 0 17 18 1 0 0 0 0 18 19 2 0 0 0 0 19 14 1 0 0 0 0 M END > DBMET03334 > drugbank > NC1=CC=C(CCNC[C@H](O)C2=CC=CC=C2)C=C1 > InChI=1S/C16H20N2O/c17-15-8-6-13(7-9-15)10-11-18-12-16(19)14-4-2-1-3-5-14/h1-9,16,18-19H,10-12,17H2/t16-/m0/s1 > TUAHDMSPHZSMQN-INIZCTEOSA-N > C16H20N2O > 256.349 > 256.157563272 > 3 > 39 > 0.9999503289871302 > 29.60599603509177 > 1 > 3 > 0 > 1 > (1R)-2-{[2-(4-aminophenyl)ethyl]amino}-1-phenylethan-1-ol > 1.93 > 2.0854680720000003 > -3.73 > 0 > 1 > 2 > 1 > 14.120924682458341 > 9.706317789503583 > 58.28 > 79.33650000000003 > 6 > 1 > 4.76e-02 g/l > (2S,3S,4S,5R)-6-{[(2-{4-[2-(2-amino-1,3-thiazol-4-yl)acetamido]phenyl}ethyl)[(2R)-2-hydroxy-2-phenylethyl]carbamoyl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid > 0 > DBMET03334 > Mirabegron M17 metabolite > 16J30IOW0V $$$$